viernes, 19 de diciembre de 2025

Biotech’s year in review ++

›
https://www.statnews.com/2025/12/18/readout-loud-podcast-biotech-venture-capital-obesity-coverage/ By Allison DeAngelis, Elaine Chen, and A...

NIH funding rates for early-career researchers plunged in 2025, new data show Change in how grants are paid undercut support for young scientists, an agency priority

›
https://www.statnews.com/2025/12/18/nih-early-career-researchers-grant-success-rate-falls/ By Anil Oza and Jonathan WosenDec. 18, 2025

Trump’s marijuana reclassification could boost research, broaden access President weighs in on debate between hard-liners and those who want more research on drug’s medical uses

›
https://www.statnews.com/2025/12/18/trump-reclassifies-marijuana-to-boost-research-and-access/ By Lev FacherDec. 18, 2025 Addiction Reporte...

Facing federal hostility, supervised consumption site points to 1,900 overdose reversals New York officials show support for OnPoint even as Trump administration criticizes harm reduction

›
https://www.statnews.com/2025/12/18/on-point-nyc-drug-consumption-site-trump-defiance/ By Lev FacherDec. 18, 2025 Addiction Reporter

5 lessons for U.S. research funding from the AIDS crisis Medicine can’t wait for Washington

›
https://www.statnews.com/2025/12/19/aids-research-federal-funding-cuts-lessons/ By Robert B. ShpinerDec. 19, 2025 Shpiner is a clinical pro...

U.K.’s state-owned investment bank shows up in the U.S., eager to spend on biotech British Business Bank has billions to put into life sciences VC firms and startups, other key sectors

›
https://www.statnews.com/2025/12/19/uk-biotech-life-sciences-investment/ By Allison DeAngelisDec. 19, 2025 Biotech Startups and Venture Cap...

I’m the former head of Pfizer R&D. I’m very worried about biopharma’s future The New York Times once called me ‘Dr. Optimistic.’ I’m not so optimistic now

›
https://www.statnews.com/2025/12/19/pharmaceutical-industry-future-rfk-jr-trump/ By John L. LaMattinaDec. 19, 2025 LaMattina is the former ...